Open research questions in Influenza Virus Research Studies
169 unresolved questions extracted from the limitations and future-work sections of 877 Influenza Virus Research Studies papers in our library. Each links back to the study that raised it.
What the literature leaves open
The study faces challenges in terms of heterogeneity among the included studies. The study also faces challenges in terms of publication bias. The study highlights the need for improved vaccination policies and strategies to increase vaccination rates among health care workers in China.
Prevalence and factors influencing influenza vaccination among health care workers in China: a systematic review and meta-analysis · 2026 · DOIThe current vaccination rate in China is still not up to the standard. There are significant differences in different regions and medical institutions. The study aims to address the gap in understanding the influenza vaccination rate and influencing factors among health care workers in China.
Prevalence and factors influencing influenza vaccination among health care workers in China: a systematic review and meta-analysis · 2026 · DOIinvestigating the relationship between innate immune responsiveness and symptomatic disease, - exploring potential targets for therapeutic intervention, - examining the role of inflammatory signals in modulating immune responses
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection · 2026 · DOIThe paper identifies a gap in understanding the early immune factors associated with clinical outcome in controlled human influenza infection. It also highlights the need for further research on the relationship between innate immune responsiveness and symptomatic disease. The study notes that the mechanisms of influenza infection are not fully understood, particularly with regards to the role of innate immune responses.
Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection · 2026 · DOIThe antigenic mismatch between stockpiled vaccines and the strain that causes a future outbreak. The accelerated antigenic drift and shift observed in H5Nx viruses. The need for integrated early warning systems to detect abnormal patterns and emerging threats.
Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines · 2025 · DOIAccelerating vaccine and drug development, especially universal vaccines, - Developing next-generation vaccine platforms designed to provide broad, long-lasting protection against a wide spectrum of HPAI virus subtypes and strains
Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines · 2025 · DOIOur study strengthens the evidence by including comprehensive safety endpoints and highlighting specific AEs that warrant further investigation in future trials and pharmacovigilance efforts.
Immunogenicity and safety of seasonal influenza vaccine co-administered with other vaccines: a systematic review and meta-analysis · 2026 · DOIDespite its high propensity for host switching, the evolutionary mechanisms underlying influenza host adaptation remain unclear.
Thus, developing alternative bovine models that maintain biological relevance while reducing operational complexity is warranted.
Pathogenesis of H5N1 Clade 2.3.4.4b in dry Jersey cows following intramammary inoculation shows within-host compartmentalization · 2026 · DOIAlthough more than 1000 herds have been infected, bovine H5N1 influenza virus pathogenesis, transmission, and evolution in dairy cattle remains not well characterized.
Pathogenesis of H5N1 Clade 2.3.4.4b in dry Jersey cows following intramammary inoculation shows within-host compartmentalization · 2026 · DOIWhile the effects of highly occupied glycosylated sites of hemagglutinin on A(H3N2) influenza A virus biology are well studied, there is limited information on the functional impact of the low-occupancy glycosylation sites on the viral hemagglutinin.
N-linked glycosylation sites with low occupancy support sustained circulation of the A(H3N2) influenza A virus in the human population · 2026 · DOIHow the resultant spatial heterogeneity shapes within-host genetic diversity and viral evolutionary pathways is poorly understood.
Dispersal of influenza virus populations within the respiratory tract shapes their evolutionary potential · 2025 · DOIWhile overall trends aligned with publicly available data, absolute counts may be under-reported within Epic due to incomplete documentation of vaccine administrations outside of Epic-affiliated systems.
Vaccine fatigue and influenza vaccination trends across Pre-, Peri-, and Post-COVID-19 periods in the United States using epic’s cosmos database · 2025 · DOIAs a result, vaccine efficacy can vary widely from one year to the next, and the wild-type antigens in the seasonal vaccine need to be updated frequently to stay current with the ever-changing viral landscape.
H3 hemagglutinin proteins optimized for 2018 to 2022 elicit neutralizing antibodies across panels of modern influenza A(H3N2) viruses · 2025 · DOIDespite pigs being an important species in influenza A virus (IAV) epidemiology and a reliable preclinical model for human IAV infections, many aspects of the porcine pulmonary immune system remain poorly understood.
Single-cell analysis of pig lung leukocytes and their response to influenza infection and oseltamivir therapy · 2025 · DOIWhile systemic hypoxemia is a feature of severe influenza infection, the impact of tissue level hypoxia on lung damage and repair during an infection have not been explored.
Exploring the impact of acute lung hypoxia on CD8 T cell phenotypes following severe influenza infection 3979 · 2025 · DOINovel vaccination strategies are under development, but mucosal immunity, which has been shown to offer increased breadth of protection, is understudied, in part due to challenges in measuring mucosal immune responses.
Engineering recombinant ferret IgA against influenza viruses and coronaviruses for reagent validation and musocal immunity assessment 4743 · 2025 · DOIHowever, limited studies have directly compared how different adjuvants might influence immune responses elicited under such dose-sparing regimens.
Differential effects of adjuvants on shaping unique B cell responses in a dose-sparing seasonal influenza vaccine 4246 · 2025 · DOIOur results indicate a high disease burden due to seasonal influenza in Germany, indicating further research into complication rates, underestimation, and intervention programs for vulnerable populations, e.
Measuring the disease burden of seasonal influenza in Germany 2015 - 2020 using the incidence-based disability-adjusted life years (DALYs) · 2025 · DOIFor paediatric patients at high risk of severe influenza, the readmission and the associated risk factors remain unclear.
Risk factors for re-hospitalization within 90 days of discharge for severe influenza in children · 2025 · DOIDue to limited surveillance, influenza dynamics in Namibia remain poorly understood.
Molecular surveillance of influenza A and B in namibia: seasonal patterns and clinical correlates (2021–2023) · 2025 · DOIBACKGROUND: Non-pharmaceutical interventions (NPIs) are critical for influenza control and prevention, however, the data about such interventions are insufficient among students in grades below middle school.
Non-pharmaceutical interventions (NPIs) to control influenza spread among children in primary school and kindergarten: class-suspension or symptom-based isolation? · 2025 · DOICurrently, there's limited research reporting on the protective effect of influenza vaccination against recurrent stroke in elderly stroke survivors.
Influenza vaccination and ischemic stroke risk reduction in elderly stroke survivors: a retrospective cohort study with negative control validation · 2025 · DOIAbstract Background Quantitative evidence on the impact of meteorological factors on influenza transmissibility across different virus types/subtypes is scarce, and no previous studies have reported the effect of hourly temperature variability (HTV) on influenza transmissibility.
While the efficacy and safety of Baloxavir Marboxil have been thoroughly characterized across an extensive clinical trial, studies on the effectiveness of Baloxavir Marboxil in a real-world setting are still scarce.
Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study · 2024 · DOI
Most-cited papers in Influenza Virus Research Studies
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans · New England Journal of Medicine · 2009 · 2,308 citations
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution · Nature · 1981 · 2,127 citations
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus · New England Journal of Medicine · 2013 · 2,085 citations
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans · Science · 2009 · 2,049 citations
- Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus · The Lancet · 1998 · 1,157 citations
- H1N1 2009 influenza virus infection during pregnancy in the USA · The Lancet · 2009 · 1,039 citations
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies · American Journal of Epidemiology · 2008 · 957 citations
- Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia · Archives of General Psychiatry · 2004 · 882 citations
- Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States · JAMA · 2010 · 832 citations
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza · JAMA · 2000 · 820 citations
Most recent work
- Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — United States, September 2025–February 2026 · MMWR Morbidity and Mortality Weekly Report · 2026
- Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season · New England Journal of Medicine · 2026
- Serologic Evidence of Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Veterinary Professional Exposed to an Infected Domestic Cat — Los Angeles County, California, December 2024–January 2025 · MMWR Morbidity and Mortality Weekly Report · 2026
- Rapid expansion of genotype D1.1 A(H5N1) influenza viruses in wild birds across North America during the 2024 migratory season · Nature Medicine · 2026
- Global, regional, and national burden of influenza-associated lower respiratory infections, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 · BMC Infectious Diseases · 2026
- Can H5N1 avian influenza in dairy cattle be contained in the US? · Cell · 2026
- Vaccine-Elicited Antibody Responses to Influenza A(H3N2) Subclade K · JAMA · 2026
- The RdRp Thumb-1 Pocket is a Conserved Target for Broad-Spectrum Antiviral Development · bioRxiv · 2026
- Human Infection with Highly Pathogenic Avian Influenza A(H5N5) Virus · New England Journal of Medicine · 2026
- Influenza Vaccine Effectiveness Among Children With and Without Underlying Conditions · PEDIATRICS · 2026
Find a gap in your own Influenza Virus Research Studies sub-topic
This page shows what the Influenza Virus Research Studies literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →